Advertisement

Topics

Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market

05:41 EST 20 Feb 2017 | Labiotech.eu

Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition with no cure.  Modus Therapeutics, previously Dilaforette, is developing sevuparin, a drug designed to restore normal blood flow in patients ...

This awesome article Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market

NEXT ARTICLE

More From BioPortfolio on "Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...